Trials / Completed
CompletedNCT02489734
Post Extubation Delirium and End-tidal Sevoflurane Concentration
Association Between Post Extubation Delirium and Pre-extubation End-tidal Sevoflurane Concentration in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Children's Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 2 Years – 7 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the incidence of emergence delirium will be reduced when end-tidal concentration of sevoflurane decreases.
Detailed description
Sevoflurane induction and maintenance were selected. Intubation was performed after lidocaine spray on vocal cord. After that, an effective caudal or brachial plexus block was performed. End-tidal concentration of sevoflurane was maintained at 2.5%. Spontaneous respiratory was maintained. Sevoflurane was stopped after the end of surgery. Patients were randomly assigned to 2 groups: high concentration group (Group HC, end-tidal concentration of sevoflurane when extubating \>=0.5%) and low concentration group (Group LC, end-tidal concentration of sevoflurane when extubating \<0.5%). Patients in Group LC were extubated when they coughed or purposeful movement appeared. The patients whose end-tidal concentration of sevoflurane \>= 0.5% were excluded. Patients in Group HC were extubated when any of the criteria was met: 1.the patient coughed or purposeful movement appeared 2.end-tidal concentration of sevoflurane decreased to 0.5%. A trained nurse (blind to groups) recorded PAEDs scores in PACU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sevoflurane | extubation when end-tidal concentration of sevoflurane \< 0.5% |
| DRUG | Sevoflurane | extubation when end-tidal concentration of sevoflurane \>= 0.5% |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-07-03
- Last updated
- 2021-08-19
- Results posted
- 2021-08-19
Source: ClinicalTrials.gov record NCT02489734. Inclusion in this directory is not an endorsement.